Gastrointestinal issues cause serious health and quality-of-life problems for people with cystic fibrosis. That's why it was good to learn about the GI-focused research and care being done.
Site Search
The recent approval of a game-changing triple-combination therapy and the announcement of a major infusion of research funding are just two reasons why we are at a pivotal time in cystic fibrosis and why this year's North American Cystic Fibrosis Conference in Nashville, Tenn., has been so exciting.
At this year's North American Cystic Fibrosis Conference in Anaheim, Calif., many of the CF Foundation's most generous and committed donors gathered to celebrate the milestones achieved over the past year in the fight against CF.
As I listened to the second plenary for this year's North American Cystic Fibrosis Conference, I couldn't help but think of my own experience with CFTR modulators and the positive effects that they have had on my health.
Finding a way to reduce lung inflammation in cystic fibrosis has challenged researchers, but we have made important advances in our understanding of this CF complication in just the last few years. Several drugs also are in development to fight another complication -- the inability to clear mucus from the lungs.
At the third plenary at this year's North American Cystic Fibrosis Conference, we explored what it means to partner in care and how to do it better.
More than 4,000 cystic fibrosis researchers and caregivers marked the 25th anniversary of the discovery of the CF gene at the 28th annual North American Cystic Fibrosis Conference (NACFC) in Atlanta. Attendees shared information on the latest in CF research and discussed the remarkable progress in treating the disease since that historic milestone.
In the largest forum of its kind, more than 4,000 doctors, scientists and caregivers from around the world are meeting today in Atlanta for the 28th annual North American Cystic Fibrosis Conference (NACFC).
The recipients of this year's Richard C. Talamo Distinguished Clinical Achievement Award, presented at the 2014 North American Cystic Fibrosis Conference, represent a successful collaboration between researchers and clinicians to bring about a significant advance in CF care and treatment. The award is one of the highest honors given by the Cystic Fibrosis Foundation.